$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

위암과 미생물총
Gastric Cancer and Non-Helicobacter pylori Microbiota 원문보기

Journal of digestive cancer research, v.12 no.1, 2024년, pp.6 - 14  

김유진 (한림대학교 의과대학 강남성심병원 소화기내과)

Abstract AI-Helper 아이콘AI-Helper

Gastric cancer is the 4th leading cause of death worldwide. The primary cause of gastric cancer is known to be Helicobacter pylori (H. pylori). The advancement of molecular biology has enabled the identification of microbiomes that could not be confirmed through cultivation, and it has been revealed...

주제어

참고문헌 (67)

  1. Anderson WF, Camargo MC, Fraumeni JF Jr, Correa P,?Rosenberg PS, Rabkin CS. Age-specific trends in incidence?of noncardia gastric cancer in US adults. JAMA 2010;303:1723-1728. https://doi.org/10.1001/jama.2010.496 

  2. Zhou F, Shi J, Fang C, Zou X, Huang Q. Gastric carcinomas?in young (younger than 40 years) Chinese patients:?clinicopathology, family history, and postresection survival.?Medicine (Baltimore) 2016;95:e2873. https://doi.org/10.1097/MD.0000000000002873 

  3. Wong BC, Lam SK, Wong WM, et al. Helicobacter pylori?eradication to prevent gastric cancer in a high-risk?region of China: a randomized controlled trial. JAMA 2004;291:187-194. https://doi.org/10.1001/jama.291.2.187 

  4. Bik EM, Eckburg PB, Gill SR, et al. Molecular analysis?of the bacterial microbiota in the human stomach. Proc?Natl Acad Sci U S A 2006;103:732-737. https://doi.org/10.1073/pnas.0506655103 

  5. Forman D, Newell DG, Fullerton F, et al. Association?between infection with Helicobacter pylori and risk of?gastric cancer: evidence from a prospective investigation.?BMJ 1991;302:1302-1305. https://doi.org/10.1136/bmj.302.6788.1302 

  6. Nomura A, Stemmermann GN, Chyou PH, Kato I, Perez-Perez GI, Blaser MJ. Helicobacter pylori infection and?gastric carcinoma among Japanese Americans in Hawaii.?N Engl J Med 1991;325:1132-1136. https://doi.org/10.1056/NEJM199110173251604 

  7. Parsonnet J, Friedman GD, Vandersteen DP, et al. Helicobacter?pylori infection and the risk of gastric carcinoma.?N Engl J Med 1991;325:1127-1131. https://doi.org/10.1056/NEJM199110173251603 

  8. Huang JQ, Hunt RH. The evolving epidemiology of Helicobacter?pylori infection and gastric cancer. Can J Gastroenterol 2003;17 Suppl B:18B-20B. https://doi.org/10.1155/2003/692808 

  9. Kawai S, Wang C, Lin Y, Sasakabe T, Okuda M, Kikuchi?S. Lifetime incidence risk for gastric cancer in the Helicobacter?pylori-infected and uninfected population in Japan:?a Monte Carlo simulation study. Int J Cancer 2022; 150:18-27. https://doi.org/10.1002/ijc.33773 

  10. Schistosomes, liver flukes and Helicobacter pylori. IARC?Monogr Eval Carcinog Risks Hum 1994;61:1-241. 

  11. Poh AR, O'Donoghue RJ, Ernst M, Putoczki TL. Mouse?models for gastric cancer: matching models to biological?questions. J Gastroenterol Hepatol 2016;31:1257-1272. https://doi.org/10.1111/jgh.13297 

  12. Yakirevich E, Resnick MB. Pathology of gastric cancer?and its precursor lesions. Gastroenterol Clin North Am 2013;42:261-284. https://doi.org/10.1016/j.gtc.2013.01.004 

  13. Hsieh YY, Tung SY, Pan HY, et al. Increased abundance?of Clostridium and Fusobacterium in gastric microbiota?of patients with gastric cancer in Taiwan. Sci Rep 2018;8:158. https://doi.org/10.1038/s41598-017-18596-0 

  14. Plummer M, Franceschi S, Vignat J, Forman D, de Martel?C. Global burden of gastric cancer attributable to Helicobacter?pylori. Int J Cancer 2015;136:487-490. https://doi.org/10.1002/ijc.28999 

  15. Nguyen TH, Mallepally N, Hammad T, et al. Prevalence?of Helicobacter pylori positive non-cardia gastric adenocarcinoma?is low and decreasing in a US population.?Dig Dis Sci 2020;65:2403-2411. https://doi.org/10.1007/s10620-019-05955-2 

  16. IARC Working Group on the Evaluation of Carcinogenic?Risks to Humans. IARC monographs on the evaluation of?carcinogenic risks to humans. Ingested nitrate and nitrite,?and cyanobacterial peptide toxins. IARC Monogr Eval?Carcinog Risks Hum 2010;94:v-vii, 1-412. 

  17. von den Velden R. Ueber vorkommen und mandgel der?freien salzsaure in magensaft bei gastrektasie. Dtsch Arch?Klin Med 1879;23:369-399. 

  18. Oppler B. Zur Kenntniss des Mageninhalts beim Carcinoma?ventriculi. Dtsch Med Wochenschr 1895;21:73-75.?German. https://doi.org/10.1055/s-0029-1199648 

  19. Heinemann PG, Ecker EE. A study of the Boas-Oppler?bacillus. J Bacteriol 1916;1:435-444. https://doi.org/10.1128/jb.1.4.435-444.1916 

  20. Giannella RA, Broitman SA, Zamcheck N. Gastric acid?barrier to ingested microorganisms in man: studies in?vivo and in vitro . Gut 1972;13:251-256. https://doi.org/10.1136/gut.13.4.251 

  21. Relevance of N-nitroso compounds to human cancer: exposures?and mechanisms. Proceedings of the IXth International?Symposium on N-Nitroso Compounds. Baden,?Austria, 1-5 September 1986. IARC Sci Publ 1987;(84):1-663. 

  22. Jakszyn P, Bingham S, Pera G, et al. Endogenous versus?exogenous exposure to N-nitroso compounds and gastric?cancer risk in the European Prospective Investigation into?Cancer and Nutrition (EPIC-EURGAST) study. Carcinogenesis 2006;27:1497-1501. https://doi.org/10.1093/carcin/bgl019 

  23. Xu L, Qu YH, Chu XD, et al. Urinary levels of Nnitroso?compounds in relation to risk of gastric cancer:?findings from the Shanghai cohort study. PLoS One?2015;10:e0117326. https://doi.org/10.1371/journal.pone.0117326 

  24. Sjostedt S, Kager L, Heimdahl A, Nord CE. Microbial?colonization of tumors in relation to the upper gastrointestinal?tract in patients with gastric carcinoma. Ann Surg 1988;207:341-346. https://doi.org/10.1097/00000658-198803000-00020 

  25. Sjostedt S, Heimdahl A, Kager L, Nord CE. Microbial?colonization of the oropharynx, esophagus and stomach?in patients with gastric diseases. Eur J Clin Microbiol 1985;4:49-51. https://doi.org/10.1007/BF02148660 

  26. Tsuda A, Suda W, Morita H, et al. Influence of protonpump?inhibitors on the luminal microbiota in the gastrointestinal?tract. Clin Transl Gastroenterol 2015;6:e89. https://doi.org/10.1038/ctg.2015.20 

  27. Minalyan A, Gabrielyan L, Scott D, Jacobs J, Pisegna?JR. The gastric and intestinal microbiome: role of proton?pump inhibitors. Curr Gastroenterol Rep 2017;19:42. https://doi.org/10.1007/s11894-017-0577-6 

  28. Li TH, Qin Y, Sham PC, Lau KS, Chu KM, Leung WK.?Alterations in gastric microbiota after H. pylori eradication?and in different histological stages of gastric carcinogenesis.?Sci Rep 2017;7:44935. https://doi.org/10.1038/srep44935 

  29. Massarrat S, Saniee P, Siavoshi F, Mokhtari R,?Mansour-Ghanaei F, Khalili-Samani S. The effect of?Helicobacter pylori infection, aging, and consumption?of proton pump inhibitor on fungal colonization?in the stomach of dyspeptic patients. Front Microbiol 2016;7:801. https://doi.org/10.3389/fmicb.2016.00801 

  30. Azab M, Doo L, Doo DH, et al. Comparison of the hospital-acquired Clostridium difficile infection risk of using?proton pump inhibitors versus histamine-2 receptor antagonists for prophylaxis and treatment of stress ulcers: a?systematic review and meta-analysis. Gut Liver 2017;11:781-788. https://doi.org/10.5009/gnl16568 

  31. Rosen R, Hu L, Amirault J, Khatwa U, Ward DV, Onderdonk?A. 16S community profiling identifies proton pump?inhibitor related differences in gastric, lung, and oropharyngeal?microflora. J Pediatr 2015;166:917-923. https://doi.org/10.1016/j.jpeds.2014.12.067 

  32. Wang K, Lin HJ, Perng CL, et al. The effect of H2-?receptor antagonist and proton pump inhibitor on microbial?proliferation in the stomach. Hepatogastroenterology 2004;51:1540-1543. 

  33. Peterson WL, Mackowiak PA, Barnett CC, Marling-Cason M, Haley ML. The human gastric bactericidal barrier:?mechanisms of action, relative antibacterial activity,?and dietary influences. J Infect Dis 1989;159:979-983. https://doi.org/10.1093/infdis/159.5.979 

  34. Choi HI, Choi JP, Seo J, et al. Helicobacter pylori-derived?extracellular vesicles increased in the gastric juices of?gastric adenocarcinoma patients and induced inflammation?mainly via specific targeting of gastric epithelial?cells. Exp Mol Med 2017;49:e330. https://doi.org/10.1038/emm.2017.47 

  35. Monstein HJ, Tiveljung A, Kraft CH, Borch K, Jonasson?J. Profiling of bacterial flora in gastric biopsies from?patients with Helicobacter pylori -associated gastritis and?histologically normal control individuals by temperature?gradient gel electrophoresis and 16S rDNA sequence?analysis. J Med Microbiol 2000;49:817-822. https://doi.org/10.1099/0022-1317-49-9-817 

  36. DeLong EF. Microbial metagenomics, metatranscriptomics,?and metaproteomics. Amsterdam: Academic Press, 2013. 

  37. Zhu Z, Ren J, Michail S, Sun F. MicroPro: using metagenomic?unmapped reads to provide insights into human?microbiota and disease associations. Genome Biol 2019;?20:154. Erratum in: Genome Biol 2019;20:214. https://doi.org/10.1186/s13059-019-1773-5 

  38. Andersson AF, Lindberg M, Jakobsson H, Backhed?F, Nyren P, Engstrand L. Comparative analysis of human?gut microbiota by barcoded pyrosequencing. PLoS?One 2008;3:e2836. https://doi.org/10.1371/journal.pone.0002836 

  39. Sohn SH, Kim N, Jo HJ, et al. Analysis of gastric body?microbiota by pyrosequencing: possible role of bacteria?other than Helicobacter pylori in the gastric carcinogenesis.?J Cancer Prev 2017;22:115-125. Erratum in: J Cancer?Prev 2017;22:267. https://doi.org/10.15430/JCP.2017.22.2.115 

  40. Williams C, McColl KE. Review article: proton pump?inhibitors and bacterial overgrowth. Aliment Pharmacol?Ther 2006;23:3-10. https://doi.org/10.1111/j.1365-2036.2006.02707.x 

  41. Shao D, Vogtmann E, Liu A, et al. Microbial characterization?of esophageal squamous cell carcinoma and gastric?cardia adenocarcinoma from a high-risk region of China.?Cancer 2019;125:3993-4002. https://doi.org/10.1002/cncr.32403 

  42. Meng C, Bai C, Brown TD, Hood LE, Tian Q. Human?gut microbiota and gastrointestinal cancer. Genomics?Proteomics Bioinformatics 2018;16:33-49. https://doi.org/10.1016/j.gpb.2017.06.002 

  43. Aviles-Jimenez F, Vazquez-Jimenez F, Medrano-Guzman R, Mantilla A, Torres J. Stomach microbiota?composition varies between patients with non-atrophic?gastritis and patients with intestinal type of gastric?cancer. Sci Rep 2014;4:4202. https://doi.org/10.1038/srep04202 

  44. Ferreira RM, Pereira-Marques J, Pinto-Ribeiro I, et al.?Gastric microbial community profiling reveals a dysbiotic?cancer-associated microbiota. Gut 2018;67:226-236. https://doi.org/10.1136/gutjnl-2017-314205 

  45. Li Q, Yu H. The role of non-H. pylori bacteria in the development?of gastric cancer. Am J Cancer Res 2020;10:2271-2281. 

  46. Dicksved J, Lindberg M, Rosenquist M, Enroth H, Jansson?JK, Engstrand L. Molecular characterization of the?stomach microbiota in patients with gastric cancer and in?controls. J Med Microbiol 2009;58:509-516. https://doi.org/10.1099/jmm.0.007302-0 

  47. Coker OO, Dai Z, Nie Y, et al. Mucosal microbiome dysbiosis?in gastric carcinogenesis. Gut 2018;67:1024-1032. https://doi.org/10.1136/gutjnl-2017-314281 

  48. Park CH, Lee AR, Lee YR, Eun CS, Lee SK, Han DS.?Evaluation of gastric microbiome and metagenomic?function in patients with intestinal metaplasia using 16S?rRNA gene sequencing. Helicobacter 2019;24:e12547. https://doi.org/10.1111/hel.12547 

  49. Wang L, Zhou J, Xin Y, et al. Bacterial overgrowth and?diversification of microbiota in gastric cancer. Eur J Gastroenterol?Hepatol 2016;28:261-266. https://doi.org/10.1097/MEG.0000000000000542 

  50. Hu YL, Pang W, Huang Y, Zhang Y, Zhang CJ. The?gastric microbiome is perturbed in advanced gastric adenocarcinoma?identified through shotgun metagenomics.?Front Cell Infect Microbiol 2018;8:433. https://doi.org/10.3389/fcimb.2018.00433 

  51. Eun CS, Kim BK, Han DS, et al. Differences in gastric?mucosal microbiota profiling in patients with chronic?gastritis, intestinal metaplasia, and gastric cancer using?pyrosequencing methods. Helicobacter 2014;19:407-416. https://doi.org/10.1111/hel.12145 

  52. Castano-Rodriguez N, Goh KL, Fock KM, Mitchell HM,?Kaakoush NO. Dysbiosis of the microbiome in gastric?carcinogenesis. Sci Rep 2017;7:15957. https://doi.org/10.1038/s41598-017-16289-2 

  53. Liu X, Shao L, Liu X, et al. Alterations of gastric mucosal?microbiota across different stomach microhabitats in a?cohort of 276 patients with gastric cancer. EBioMedicine 2019;40:336-348. https://doi.org/10.1016/j.ebiom.2018.12.034 

  54. Stewart OA, Wu F, Chen Y. The role of gastric microbiota?in gastric cancer. Gut Microbes 2020;11:1220-1230. https://doi.org/10.1080/19490976.2020.1762520 

  55. Vuik F, Dicksved J, Lam SY, et al. Composition of the?mucosa-associated microbiota along the entire gastrointestinal?tract of human individuals. United European?Gastroenterol J 2019;7:897-907. https://doi.org/10.1177/2050640619852255 

  56. Maldonado-Contreras A, Goldfarb KC, Godoy-Vitorino F,?et al. Structure of the human gastric bacterial community?in relation to Helicobacter pylori status. ISME J 2011;5:574-579. https://doi.org/10.1038/ismej.2010.149 

  57. Lofgren JL, Whary MT, Ge Z, et al. Lack of commensal?flora in Helicobacter pylori -infected INS-GAS mice reduces?gastritis and delays intraepithelial neoplasia. Gastroenterology 2011;140:210-220. https://doi.org/10.1053/j.gastro.2010.09.048 

  58. Allison CC, Ferrero RL. Role of virulence factors and?host cell signaling in the recognition of Helicobacter pylori?and the generation of immune responses. Future Microbiol 2010;5:1233-1255. https://doi.org/10.2217/fmb.10.84 

  59. Graham DY. Helicobacter pylori update: gastric cancer,?reliable therapy, and possible benefits. Gastroenterology?2015;148:719-731.e3. https://doi.org/10.1053/j.gastro.2015.01.040 

  60. Miftahussurur M, Yamaoka Y, Graham DY. Helicobacter?pylori as an oncogenic pathogen, revisited. Expert Rev?Mol Med 2017;19:e4. https://doi.org/10.1017/erm.2017.4 

  61. Hanada K, Graham DY. Helicobacter pylori and the molecular?pathogenesis of intestinal-type gastric carcinoma.?Expert Rev Anticancer Ther 2014;14:947-954. https://doi.org/10.1586/14737140.2014.911092 

  62. Kidane D. Molecular mechanisms of H. pylori -induced?DNA double-strand breaks. Int J Mol Sci 2018;19:2891. https://doi.org/10.3390/ijms19102891 

  63. Gunathilake MN, Lee J, Choi IJ, et al. Association between?the relative abundance of gastric microbiota and?the risk of gastric cancer: a case-control study. Sci Rep?2019;9:13589. Erratum in: Sci Rep 2021;11:21669. https://doi.org/10.1038/s41598-019-50054-x 

  64. Montalban-Arques A, Wurm P, Trajanoski S, et al. Propionibacterium?acnes overabundance and natural killer?group 2 member D system activation in corpus-dominant?lymphocytic gastritis. J Pathol 2016;240:425-436. https://doi.org/10.1002/path.4782 

  65. Ling Z, Shao L, Liu X, et al. Regulatory T cells and?plasmacytoid dendritic cells within the tumor microenvironment?in gastric cancer are correlated with?gastric microbiota dysbiosis: a preliminary study.?Front Immunol 2019;10:533. https://doi.org/10.3389/fimmu.2019.00533 

  66. Huang XM, Liu XS, Lin XK, et al. Role of plasmacytoid dendritic cells and inducible costimulator-positive regulatory?T cells in the immunosuppression microenvironment?of gastric cancer. Cancer Sci 2014;105:150-158. https://doi.org/10.1111/cas.12327 

  67. Ahmetlic F, Riedel T, Homberg N, et al. Regulatory T?cells in an endogenous mouse lymphoma recognize specific?antigen peptides and contribute to immune escape.?Cancer Immunol Res 2019;7:600-608. https://doi.org/10.1158/2326-6066.CIR-18-0419 

관련 콘텐츠

이 논문과 함께 이용한 콘텐츠

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로